Product Information

LAMICTAL 25 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $10.2752 per EA under NDC 00173063302. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LAMICTAL 25 MG TABLET

lamotrigine
$10.2752per EA
High Outlier

Strength

25 mg/1

NDC

00173063302

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LAMOTRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA020241

On Market Since

8/15/1996

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMICTAL 25 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 63.8%. The table below summarizes its recorded NADAC range and movement.

Current price$10.2752 per EA
All-time high$15.2417 (Dec 20, 2023)
All-time low$6.2721 (Nov 28, 2013)
52-week high$10.3531
52-week low$10.2744
Median price$11.1987
Average price$11.2608
Largest weekly change-34.5% (Dec 27, 2023)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.0%

3M

-0.2%

6M

-0.1%

1Y

-0.8%

3Y

-32.6%

5Y

-22.3%

All

+63.8%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LAMICTAL 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL 25 MG TABLET, manufactured by GlaxoSmithKline LLC, is $10.2752 per EA (NDC 00173063302), effective Jun 24, 2026.

How has the price of LAMICTAL 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMICTAL 25 MG TABLET has risen 63.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMICTAL 25 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMICTAL 25 MG TABLET has ranged from a low of $6.2721 (Nov 28, 2013) to a high of $15.2417 (Dec 20, 2023), with a median of $11.1987 per EA.

Are there cheaper alternatives to LAMICTAL 25 MG TABLET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LAMOTRIGINE 25 MG DISPER TAB, is $0.1613 per EA — about 98% below LAMICTAL 25 MG TABLET.

Who manufactures LAMICTAL 25 MG TABLET?

LAMICTAL 25 MG TABLET (NDC 00173063302) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.